These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34997957)

  • 81. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
    Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
    Front Immunol; 2019; 10():240. PubMed ID: 30858847
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy.
    Fakhouri F; Vercel C; Frémeaux-Bacchi V
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2100-6. PubMed ID: 22879435
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S; Fervenza FC
    Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A New Paradigm for Renal Thrombotic Microangiopathy.
    Gallan AJ; Chang A
    Semin Diagn Pathol; 2020 May; 37(3):121-126. PubMed ID: 32085935
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.
    El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP
    Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Complement-mediated thrombotic microangiopathy associated with lupus nephritis.
    Park MH; Caselman N; Ulmer S; Weitz IC
    Blood Adv; 2018 Aug; 2(16):2090-2094. PubMed ID: 30131343
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation.
    Broeders EN; Stordeur P; Rorive S; Dahan K
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25538218
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Genetic, clinical, and pathological study of patients with severe hypertension-associated renal microangiopathy.
    Chen X; Zhang X; Wang Y; Wang S; Zhao M
    J Nephrol; 2023 Dec; 36(9):2477-2490. PubMed ID: 37103770
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Cavero T; Arjona E; Soto K; Caravaca-Fontán F; Rabasco C; Bravo L; de la Cerda F; Martín N; Blasco M; Ávila A; Huerta A; Cabello V; Jarque A; Alcázar C; Fulladosa X; Carbayo J; Anaya S; Cobelo C; Ramos N; Iglesias E; Baltar J; Martínez-Gallardo R; Pérez L; Morales E; González R; Macía M; Draibe J; Pallardó L; Quintana LF; Espinosa M; Barros X; Pereira F; Cao M; Moreno JA; Rodríguez de Córdoba S; Praga M;
    Kidney Int; 2019 Oct; 96(4):995-1004. PubMed ID: 31420192
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
    Bu F; Borsa NG; Jones MB; Takanami E; Nishimura C; Hauer JJ; Azaiez H; Black-Ziegelbein EA; Meyer NC; Kolbe DL; Li Y; Frees K; Schnieders MJ; Thomas C; Nester C; Smith RJ
    J Am Soc Nephrol; 2016 Apr; 27(4):1245-53. PubMed ID: 26283675
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
    Laboux T; Maanaoui M; Allain F; Boulanger E; Denys A; Gibier JB; Glowacki F; Grolaux G; Grunenwald A; Howsam M; Lancel S; Lebas C; Lopez B; Roumenina L; Provôt F; Gnemmi V; Frimat M
    Kidney Int; 2023 Aug; 104(2):353-366. PubMed ID: 37164260
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab.
    Puri P; Hanxhiu A; O'Hara DV; Hsu D; Vucak-Dzumhur M
    BMC Nephrol; 2020 Nov; 21(1):488. PubMed ID: 33203373
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
    Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
    J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
    Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
    Avila Bernabeu AI; Cavero Escribano T; Cao Vilarino M
    Nephron; 2020; 144(11):537-549. PubMed ID: 32950988
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characteristics and management of thrombotic microangiopathy in kidney transplantation.
    Cho W; Jo SK; Jung CW; Kim MG
    Korean J Transplant; 2023 Mar; 37(1):11-18. PubMed ID: 37064766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.